Financial Results

Scheme of Arrangement

Inter-alia to transact the following businesses as under: 1. To consider the appointment of Chief Financial Officer (CFO) of the Company. 2. To consider the Proposal to raise funds through issuance of equity shares by way of a rights issue permitted under applicable law, subject to requisite regulatory and statutory approvals 3. Any other business with the permission of the Chair.

Inter alia, to consider and approve :- a) To take on record Secretarial Audit Report for the F.Y. 2025 26; b) To approve the Director?s Report and related annexures for the F.Y. 2025 26; c) To fix the date of the 43rd Annual General Meeting (?AGM?) and approve draft notice of AGM and other incidental matters;

Quarterly Results

Fund Raising/Other business matters

Other business matters

Inter alia to consider and approve the following: - I. To consider and approve Sub-division of Equity Shares of the Company. 2. To approve alteration of Capital Clause of Memorandum of Association of the Company subject to approval from shareholders by way of postal ballot. 3. To approve draft of notice to be sent to shareholders and calendar of events pursuant to proposed postal ballot, 4. To approve the record date to be fixed for determining the eligibility of members to cast their votes on the proposed postal ballot. 5. Any other business with the permission of Chairman.

Inter alia,to consider :- 1. Resignation of Chief Financial Officer (Key Managerial Personnel) of the Company. 2. Appointment of Chief Financial Officer (Key Managerial Personnel) of the Company . 3. And any other business with the permission of chair.

Financial Results

Fund Raising through Unsecured Term Loan Facility

Inter alia, to consider and approve the following: - 1. Ratification of Approval for member's resolution passed in the Extra-Ordinary General Meeting dated 01tt November,2025. The Shareholders approval for the above allotment was earlier received vide Video Conferencing at Extra-Ordinary General Meeting on l't November 2025 andreceived the BSE in-principle approval for the same on 9ft January 2026 vide letter dated 9th January 2026. However, as per instructions of BSE, the Company is required to ratify the allotment, since the allotment was considered to be not completed within 15 days of receipt of in-principle approval. Hence, the Company proposes to consider the same at the forthcoming Shareholders meeting via Postal Ballot for ratification by the shareholders under regulation 170(2) of SEBI (ICDR) Regulations. 2. To approve draft of notice of postal ballot to approve the above-mentioned agenda; 3. Any other business with the permission of Chairman.

Inter-alia, toconsider, discuss, and approve the following:- 1. Review and Re-discussion of Earlier approved Convertible Warrants: To review and re-discuss the earlier approved 60,00,000 (Sixty Lakhs) Convertible Warrants ("Warrants") on a preferential basis, approved in the Board meeting held on June 1, 2026, and to take any decision(s) consequential thereto. 2. Consequential Revision of Extra-Ordinary General Meeting (EGM) Schedule: To approve and if thought fit to reschedule, and revise the date of the Extraordinary General Meeting (EGM) of the shareholders of the Company, which was originally scheduled to be held on Tuesday, June 30, 2026, and to fix a revised date, time, and mode for the EGM. 3. Appointment of Professional Intermediaries: To consider, approve, and authorize the appointment of the following intermediaries for the proposed preferential issue: i. Registered Valuer: For determining and ratifying the valuation and pricing of the proposed warrants issue under applicable SEBI and Companies Act provisions. ii. Scrutinizer: To oversee and conduct the e-voting process for the EGM in a fair, secure, and transparent manner. iii. Monitoring Agency: To monitor the utilization of proceeds arising from the proposed preferential issue of warrants under SEBI regulations.

Fund Raising Interalia, to consider raising of funds by issue of equity shares and/or other securities convertible into equity shares, in one or more tranches, through permissible modes, including but not limited to private placement / preferential issue, or any other method or combination of methods, on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, in accordance with the applicable provisions of the Companies Act, 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and any other applicable law, subject to the receipt of necessary approvals, including the approval of the members of the Company and such other regulatory and statutory approvals as may be required.